Selective Serotonin Reuptake Inhibitor
Fluoxetine for Anxiety and Depression
Recruiting0 awardsPhase 2
Bethesda, Maryland
This trial uses fMRI to study brain regions engaged in processing motivationally salient stimuli in children, adolescents, and adults with mood and anxiety disorders, in order to better understand how these disorders develop and how they can be treated.
Device Validation Using Blood Samples for Thrombotic Thrombocytopenic Purpura
Recruiting0 awards
Berkeley, California
This trial is for a new device that needs to be validated with known samples. 3 ml of blood is needed from people diagnosed with hTTP. You will be compensated for your time and resources.
Blood Collection Device Validation for Patients Taking Blood Thinners
Recruiting0 awards4 criteria
Berkeley, California
This trial is to help a manufacturer qualify their line of blood collection tubes with the FDA, which will help increase the supply of blood collection tubes. Participants on anticoagulants such as Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox® are compensated for their time and resources (up to $200 for a 3.5 tablespoon blood draw).
Blood Collection Device Validation for Patients on Blood Thinners
Recruiting0 awards4 criteria
Berkeley, California
This trial is for a medical device manufacturer to qualify their line of blood collection tubes with the FDA. Participants who are currently on anticoagulants will be compensated for their time and resources.
Cell Therapy
Islet Cell Transplant for Type 1 Diabetes
Recruiting1 awardPhase 1 & 2
Chicago, Illinois
This trial is testing if it's safe to transplant human islet cells to help control blood sugar in type 1 diabetes patients who have trouble controlling it. Early observations will also be made about if this treatment can help with hypoglycemia.
Radioactive Antibody Treatment for Multiple Myeloma
Recruiting1 awardPhase 2
Ann Arbor, Michigan
This trial is for patients with newly diagnosed or relapsed multiple myeloma who will receive consolidation treatment with Bexxar, a radioactive antibody. The study will look at how patients respond to the treatment and what side effects occur.
Popular Filters
Trials for Adenocarcinoma Patients
Hormone Therapy
Androgen Ablation Therapy + Chemotherapy for Prostate Cancer
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is studying androgen-ablation therapy and docetaxel to see how well they work compared to androgen-ablation therapy alone in treating patients with metastatic prostate cancer.
Trials for Acute Lymphoblastic Leukemia Patients
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitors for Hypereosinophilic Syndrome
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is for patients with a rare blood disorder called hypereosinophilic syndrome, who have not responded to standard treatment. The study will test whether the drug imatinib mesylate (Gleevec) is safe and effective in reducing blood eosinophils in these patients.
Alkylating agents
Chemoradiotherapy + Stem Cell Transplant for Blood Cancers
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving chemotherapy drugs and HT before a donor stem cell transplant to see if it helps stop the growth of cancer cells and also helps stop the patient's immune system from rejecting the donor's stem cells.
Phase 3 Trials
Corticosteroid
Breztri/Trixeo for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Panorama City, California
This trial tests if a triple medication inhaler can improve heart and lung health in high-risk COPD patients better than a dual medication inhaler. Using a single inhaler with three medications has been shown to improve lung function and reduce flare-ups in COPD patients compared to using two medications, but it may increase the risk of pneumonia.
Hormone Therapy
Androgen Ablation Therapy + Chemotherapy for Prostate Cancer
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is studying androgen-ablation therapy and docetaxel to see how well they work compared to androgen-ablation therapy alone in treating patients with metastatic prostate cancer.
Anti-metabolites
Chemotherapy +/− Bevacizumab for Breast Cancer
Recruiting1 awardPhase 3
Anniston, Alabama
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Trials With No Placebo
Behavioral Intervention
Pelvic Floor Physical Therapy + Psychosocial Treatment for Bladder Pain Syndrome
Recruiting1 award2 criteria
Franklin, Tennessee
"This trial aims to understand how different subgroups of patients with interstitial cystitis/bladder pain syndrome respond to two common treatments - pelvic floor physical therapy and cognitive-behavioral therapy. The goal
Alkylating agents
Hepatic Arterial Infusion + Chemotherapy for Colorectal Cancer Liver Metastases
Recruiting1 awardPhase 1
New Brunswick, New Jersey
This trial is testing a new cancer treatment for people who have had part of their liver removed. It's a combination of two drugs given through an IV, plus a third drug given through a pump that goes directly to the liver. The goal is to find the best dose of each drug to give, based on how well the patient tolerates the treatment.
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitors for Hypereosinophilic Syndrome
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is for patients with a rare blood disorder called hypereosinophilic syndrome, who have not responded to standard treatment. The study will test whether the drug imatinib mesylate (Gleevec) is safe and effective in reducing blood eosinophils in these patients.
Corticosteroid
Breztri/Trixeo for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Panorama City, California
This trial tests if a triple medication inhaler can improve heart and lung health in high-risk COPD patients better than a dual medication inhaler. Using a single inhaler with three medications has been shown to improve lung function and reduce flare-ups in COPD patients compared to using two medications, but it may increase the risk of pneumonia.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.